Holotranscobalamin - a sensitive marker of cobalamin malabsorption

Eur J Clin Invest. 1999 Apr;29(4):321-9. doi: 10.1046/j.1365-2362.1999.00446.x.

Abstract

Background: No simple and reliable method of identifying patients with cobalamin malabsorption is available at present. The measurement of plasma holotranscobalamin, i.e. the metabolically active cobalamins bound to the transport protein transcobalamin, has been suggested as a means of fulfilling such criteria.

Design: We describe a method that directly quantifies cobalamins attached to transcobalamin. The method is evaluated in patients referred for gastrointestinal examination because of suspected cobalamin malabsorption.

Results: Of the 101 patients referred, all 48 with gastrointestinal conditions compatible with cobalamin malabsorption had plasma holotranscobalamin below 35 pmol L-1 (interval of 35-160pmol L-1). None of the patients with plasma holotranscobalamin above the lower reference limit had conditions compatible with cobalamin malabsorption.

Conclusion: The values obtained for plasma holotranscobalamin showed a better correlation with possible malabsorption than the values obtained for plasma cobalamins. The specificity of the test, however, needs to be elucidated further.

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Atrophy
  • Female
  • Gastric Mucosa / metabolism
  • Gastric Mucosa / pathology
  • Homocysteine / blood
  • Humans
  • Intestinal Absorption / physiology*
  • Male
  • Methylmalonic Acid / blood
  • Middle Aged
  • Stomach / pathology
  • Transcobalamins / analysis
  • Transcobalamins / metabolism*
  • Vitamin B 12 / pharmacokinetics*
  • Vitamin B 12 Deficiency / metabolism*

Substances

  • Transcobalamins
  • Homocysteine
  • Methylmalonic Acid
  • Vitamin B 12